# Treatment of Recurrent Hepatitis C After Liver Transplantation

> **NCT00151580** · PHASE3 · COMPLETED · sponsor: **Rennes University Hospital** · enrollment: 200 (actual)

## Conditions studied

- Liver Transplantation
- Hepatitis C

## Interventions

- **DRUG:** Ribavirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00151580
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2012-05-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151580, "Treatment of Recurrent Hepatitis C After Liver Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00151580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*